Tag: growth

Taronis Fuels Spin-Off On Schedule for Immediate Completion

November 29th Record Date, Stock Distribution December 5th PHOENIX, AZ, Nov. 27, 2019 (GLOBE NEWSWIRE) — Taronis Technologies, Inc., (“Taronis” or “the Company”) (NASDAQ: TRNX), a leading renewable fuel producer serving the global industrial gas markets, today announced that it is on schedule to complete the Taronis Fuels spin-off as previously scheduled. November 29, 2019 is […]

Read more
CORRECTED-Takeda says cancer drug Alunbrig shows longer benefit vs crizotinib

(This Nov. 23rd story corrects fiscal year of expected regulatory approval in the 10th paragraph to March-end 2021, not March-end 2020) FILE PHOTO: Takeda Pharmaceutical Co’s logo is seen at its headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon/File Photo By Rocky Swift (Reuters) – Japan’s biggest drugmaker, Takeda Pharmaceutical Co Ltd, said long-term […]

Read more
Takeda says cancer drug Alunbrig shows longer benefit vs. crizotinib

(Reuters) – Japan’s biggest drugmaker, Takeda Pharmaceutical Co Ltd, said long-term data show better outcomes for its Alunbrig drug in certain lung cancer patients compared to an existing treatment. FILE PHOTO: Takeda Pharmaceutical Co’s logo is seen at its headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon/File Photo Oncology is a pillar for Takeda […]

Read more
Moscow Region presents its investment potential in New Delhi

On November 12-14, representatives of the Indian business community had a chance to learn about doing business in Russia firsthand. At the initiative of Moscow Region Governor Andrei Vorobyov, the delegation of Moscow Region visited New Delhi to present business and investment opportunities available in the region and expand cooperation with Indian partners. According to […]

Read more
Taronis Technologies Reports Q3 Earnings Company Reports Revenues of $5.3 Million,  103% Increase vs. Third Quarter 2018

PHOENIX, AZ, Nov. 20, 2019 (GLOBE NEWSWIRE) — Taronis Technologies, Inc., (“Taronis” or “the Company”) (NASDAQ: TRNX), a leading renewable fuel producer serving the global industrial gas markets, today announced third quarter 2019 results of operation. Revenues generated in the third quarter were $5.3 million, representing a 103% increase over the third quarter of 2018. The […]

Read more
Taronis Announces Third Quarter Earning Call

Shareholder Call Scheduled for November 20th PHOENIX, AZ, Nov. 19, 2019 (GLOBE NEWSWIRE) — Taronis Technologies, Inc., (“Taronis” or “the Company”) (NASDAQ: TRNX), a leading clean technology company in the renewable resources and environmental conservation industry, today announced it will hold a shareholder town hall meeting via teleconference on Wednesday, November 20th at 9:00am EST. […]

Read more
Taronis Launches Turkish Joint Venture

JV Formed to Support Expanded Turkish Business Model PHOENIX, AZ , Nov. 14, 2019 (GLOBE NEWSWIRE) — Taronis Technologies, Inc., (“Taronis” or “the Company”) (NASDAQ: TRNX), a leading renewable fuel producer serving the global industrial gas markets, today announced the formation of a new joint venture within the Republic of Turkey. The new Turkish company is […]

Read more
J&J blockbuster loses ground to biosimilars despite Quebec court ruling

TORONTO/MONTREAL (Reuters) – Johnson & Johnson’s (JNJ.N) Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec’s public drug program, even after a court ruling reinstated full coverage in January, a Reuters analysis of government data shows. FILE PHOTO: The company logo for […]

Read more
Taronis Technologies Compliant with Nasdaq Listing Criteria

PHOENIX, AZ, Nov. 12, 2019 (GLOBE NEWSWIRE) — Taronis Technologies, Inc., (“Taronis” or “the Company”) (NASDAQ: TRNX), a leading renewable fuel producer serving the global industrial gas markets, today announced that it has evidenced full compliance with all criteria for continued listing on Nasdaq. By letter dated November 8, 2019, Nasdaq informed the Company that it […]

Read more

LOS ANGELES (Reuters) – Amgen Inc (AMGN.O) said on Thursday it will take a 20.5% stake in BeiGene Ltd (6160.HK) in a deal to expand the California-based biotechnology company’s presence in China, the world’s second largest pharmaceutical market. FILE PHOTO: An Amgen sign is seen at the company’s office in South San Francisco, California October […]

Read more